Vaccination with Formulation of Nanoparticles Loaded with <i>Leishmania amazonensis</i> Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster

Vaccination with Formulation of Nanoparticles Loaded with <i>Leishmania amazonensis</i> Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster

Visceral leishmaniasis (VL) is a fatal disease caused by the protozoa <i>Leishmania infantum</i> for which dogs are the main reservoirs. A vaccine against canine visceral leishmaniasis (CVL) could be an important tool in the control of human and CVL by reducing the infection pressure of...

Full description

Bibliographic Details
Main Authors: Marco Antonio Cabrera González, Ana Alice Maia Gonçalves, Jennifer Ottino, Jaqueline Costa Leite, Lucilene Aparecida Resende, Otoni Alves Melo-Júnior, Patrícia Silveira, Mariana Santos Cardoso, Ricardo Toshio Fujiwara, Lilian Lacerda Bueno, Renato Lima Santos, Tatiane Furtado de Carvalho, Giani Martins Garcia, Paulo Ricardo de Oliveira Paes, Alexsandro Sobreira Galdino, Miguel Angel Chávez-Fumagalli, Marília Martins Melo, Denise Silveira-Lemos, Olindo Assis Martins-Filho, Walderez Ornelas Dutra, Vanessa Carla Furtado Mosqueira, Rodolfo Cordeiro Giunchetti
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Vaccines
Subjects:
visceral leishmaniasis
nanotechnology
vaccine
Online Access:https://www.mdpi.com/2076-393X/11/1/111

Similar Items

Similar Items